glp-1 and tamoxifen The Impact Safety of GLP‐1 Agents and Breast Cancer 2 Years of Endocrine Therapy,

There also have been no clinical trials to see if Rybelsus is safe or effective for people under the age of 18 (Novo Nordisk, 2021)

[DOI] [PMC free article] [PubMed] [Google Scholar] Hernandez N.S., Ige K.Y., Mietlicki-Baase E.G., Molina-Castro G.C., Turner C.A., Hayes M.R., Schmidt H.D

GLP-1s are processed by the kidneys

doi: 10.1016/j.cell.2013.12.016

According to a study published in the Journal of the American Medical Association , patients on GLP-1 therapies experience significantly higher rates of gastrointestinal adverse events compared with non-users

Collectively, these intertwined metabolic, inflammatory, and hemodynamic processes underpin the development and progression of DKD (Fig